Fcγ receptor polymorphisms determine the magnitude of in vitro phagocytosis of Streptococcus pneumoniae mediated by pneumococcal conjugate sera

Journal of Infectious Diseases

Volumn 180, Issue 3, 1999, Pages 888-891

  Jansen, Wouter T M ^a   Breukels, Mijke A ^b   Snippe, Harm ^a   Sanders, Lieke A M ^b   Verheul, André F M ^a,c   Rijkers, Ger T ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c INTERVET INTERNATIONAL BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; PNEUMOCOCCUS VACCINE; BACTERIAL VACCINE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; IMMUNOGLOBULIN ALLOTYPE; IMMUNOGLOBULIN G; MENINGOCOCCUS VACCINE; VACCINE;

ALLOTYPE; ARTICLE; CONJUGATE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; NEUTROPHIL; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; VACCINATION; ADULT; BLOOD; COMPARATIVE STUDY; GENETICS; HOMOZYGOTE; IMMUNOLOGY; POLYMERASE CHAIN REACTION;

ADULT; BACTERIAL VACCINES; HOMOZYGOTE; HUMANS; IMMUNOGLOBULIN ALLOTYPES; IMMUNOGLOBULIN G; MENINGOCOCCAL VACCINES; PHAGOCYTOSIS; PNEUMOCOCCAL VACCINES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, IGG; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 0033192439     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314920     Document Type: Article

References (13)

1. 1. Jansen WTM, Gootjes J, Zelle M, et al. Use of highly encapsulated Streptococcus pneumoniae strains in a flow cytometric assay for the assessment of the phagocytic capacity of serotype specific antibodies. Clin Diagn Lab Immunol 1998;5:703-8.
2. 2. van der Pol WJ, van de Winkel JGJ. IgG receptor polymorphisms: risk factors for disease. Immunogenetics 1998;48:222-32.
3. 3. Sanders EAM, van de Winkel JGJ, Rijkers GT, et al. Fcγ receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 1994;170:854-8.
4. 4. Huizinga TWJ, Roos D, von dem Borne AEGK. Fc-γ receptors: mediators, targets, and markers of disease. Baillieres Clin Haematol 1991;4:889-902.
5. 5. Anderson P, Betts R. Human adult immunogenicity of protein coupled pneumococcal capsular antigens of serotypes prevalent in otitis media. J Pediatr Dis 1989;8:S50.
6. 6. Sanders EAM, Rijkers GT, Tenbergen Meeskens AM, Voorhorst Ogink MM, Zegers BJM. Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infections. Pediatr Res 1995;37:812-8.
7. 7. Siber GR, Ambrosino DM, McIver J, et al. Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis. Infect Immun 1984;45:248-8.
8. 8. Haas de M, Kleijer M, van Zwieten R, Roos D, von dem Borne AEGK. Neutrophil Fc-γRIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood 1995;86:2403-54.
9. 9. Go ES, Ballas MD. Anti-pneumococcal response in normal subjects: a meta-analysis. J Allergy Clin Immunol 1996;98:205-10.
10. 10. Platonov AE, Shipulin GA, Vershinina IV, Dankert J, van de Winkel JGJ, Kuijper EJ. Association of human Fc-γRIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease. Clin Infect Dis 1998;27:746-5.
11. 11. Rodriguez ME, van der Pol W, Sanders LA, van de Winkel JGJ. Crucial role of Fc-γRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera. J Infect Dis 1999;179:423-33.
12. 12. Preud'homme J, Hanson LA. IgG subclass deficiency. Immunodefic Rev 1990;2:129-49.
13. 13. Friejd A, Hammarstroem L, Persson MAA, Smith CIE. Plasma anti-pneumococcal antibody activity of the IgG class and subclass in otitis prone children. Clin Exp Immunol 1984;56:233-6.